Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05395377 · ClinicalTrials.gov registry record · NA
Preventing Diabetes
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT05395377: Completed NA study, sponsored by Geisinger Clinic.
NCT05395377 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05395377, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
The purpose of this project is to improve the quality of weight management care for patients with pre-diabetes and overweight or obesity. Personalized risk profiles, clinical decision support, and patient-centered decision tools for understanding pre-diabetes risk and the likelihood of preventing diabetes with a modest 5-7% weight loss will be developed. This project will offer patients their choice of effective weight management treatment options, each containing the cornerstone of weight management- intensive lifestyle intervention. Patients and PCPs will be better informed and equipped with information that helps them make weight management treatment decisions that work the best for their lifestyle, and each is expected to produce at least 5-7% weight loss over 6 months.
Primary Outcome
Race, ethnicity, education level, marital status, household income, and weight management history.
Interventions
- BEHAVIORAL Diabetes Prevention Program
- BEHAVIORAL Registered Dietitian/Nutritionist
- BEHAVIORAL Weight Watchers, Reimagined
- BEHAVIORAL DPP or RDN Counseling + Medication
- OTHER Bariatric Surgery Evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2017-12-18 |
| Est. Completion | 2021-11-16 |
| Phase | NA |
What the finished NCT05395377 record still lists
NCT05395377 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 5 interventions - of which Diabetes Prevention Program is the first listed.
NCT05395377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05395377 about?
NCT05395377 is a clinical study titled "Preventing Diabetes". The purpose of this project is to improve the quality of weight management care for patients with pre-diabetes and overweight or obesity. Personalized risk profiles, clinical decision support, and patient-centered decision tools for understanding pre-diabetes risk and the likelihood of preventing di...
What is the current status of trial NCT05395377?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2017-12-18. Estimated completion is 2021-11-16.
What interventions are being tested in trial NCT05395377?
The interventions under investigation include: Diabetes Prevention Program (BEHAVIORAL), Registered Dietitian/Nutritionist (BEHAVIORAL), Weight Watchers, Reimagined (BEHAVIORAL), DPP or RDN Counseling + Medication (BEHAVIORAL), Bariatric Surgery Evaluation (OTHER).
Who is sponsoring clinical trial NCT05395377?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05395377's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI